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Background
The airway epithelium constitutes the first line of defense
in the protection against invading pathogens. It acts as a
barrier, but it is also is a major source of early released
inflammatory mediators, which help shape the inflamma-
tory response. Neuropeptides, such as substance P (SP),
have long been considered to be early contributors to the
inflammatory response, causing pain hypersensitivity and
vasodilation, as well as activation and infiltration of various
immune cells. Toll-like receptor 7 (TLR7) is found on the
epithelial cells and is known to be activated by viruses.
The present study has investigated the relationship
between TLR7 activation/expression and SP release/
stimulation.
Method
Human nasal epithelial cells (HNEC) were obtained
through nasal brushing of 6 healthy donors. The cells
were cultured until passage 4 and thereafter stimulated
with the TLR7 agonists R-837 or R-848 (1, 5 or 10μg/ml)
for 15 min, 30 min or 4h. The subsequent release of SP
was analyzed with EIA. In addition, HNECs were stimu-
lated with SP (10, 50 or 100nM) for 30 minutes in the
presence or absence of NK-1 antagonist Aprepitant.
Expression of Toll-like receptors was then determined
using flow cytometry.
Results
HNECs produced substance P in a concentration-
dependent manner in response to both R-837 and
R-848. Increased levels of SP were detected already
after 15 minutes, and increased successively over time.
SP stimulation increased not only the TLR7 expression
in HNECs, but also expression of TLR1, 4 and 9 on
these cells. Aprepitant effectively blocked this response.
Conclusion
The presented results suggest a role for SP in modulating
the local innate immune response in the nose.
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